N. Sarper, Intzi Tachzin, Sema Aylan Gelen, E. Zengin
{"title":"小儿急性骨髓细胞白血病的治疗结果;一线治疗的结果以及造血干细胞移植对复发患者存活率的贡献","authors":"N. Sarper, Intzi Tachzin, Sema Aylan Gelen, E. Zengin","doi":"10.55730/1300-0144.5806","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":509010,"journal":{"name":"Turkish Journal of Medical Sciences","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients\",\"authors\":\"N. Sarper, Intzi Tachzin, Sema Aylan Gelen, E. Zengin\",\"doi\":\"10.55730/1300-0144.5806\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":509010,\"journal\":{\"name\":\"Turkish Journal of Medical Sciences\",\"volume\":\"53 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkish Journal of Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55730/1300-0144.5806\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55730/1300-0144.5806","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients